Vertex Pharmaceuticals Inc / Ma
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/29/2026 | 2,095 | 0.0% | 4,622 | 12/31/2025 |
| 2025 Q3 | 11/6/2025 | 1,810 | 0.0% | 4,622 | 9/30/2025 |
| 2025 Q2 | 8/8/2025 | 2,058 | 0.0% | 4,622 | 6/30/2025 |
| 2025 Q1 | 4/29/2025 | 3,393 | 0.0% | 6,999 | 3/31/2025 |
| 2024 Q4 | 2/4/2025 | 2,788 | 0.0% | 6,924 | 12/31/2024 |
| 2024 Q3 | 11/6/2024 | 3,457 | 0.0% | 7,433 | 9/30/2024 |
| 2024 Q2 | 11/8/2024 | 25,028 | 0.1% | 53,396 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 28,324 | 0.1% | 67,758 | 3/31/2024 |
| 2023 Q4 | 1/26/2024 | 34,306 | 0.1% | 84,313 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 193,729 | 0.9% | 558,138 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 205,126 | 0.8% | 583,920 | 6/30/2023 |
| 2023 Q1 | 5/10/2023 | 239,738 | 1.0% | 762,347 | 3/31/2023 |
| 2022 Q4 | 2/9/2023 | 220,215 | 1.0% | 764,011 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 201,646 | 1.0% | 697,733 | 9/30/2022 |
| 2022 Q2 | 8/11/2022 | 203,152 | 1.0% | 720,934 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 224,610 | 0.9% | 860,672 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 226,814 | 0.8% | 1,032,855 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 194,946 | 0.8% | 1,074,736 | 9/30/2021 |
| 2021 Q2 | 8/5/2021 | 152,337 | 0.7% | 755,527 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 19,118 | 0.1% | 88,968 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 17,861 | 0.1% | 75,572 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 17,740 | 0.2% | 65,191 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 13,514 | 0.1% | 46,550 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 12,533 | 0.2% | 52,671 | 3/31/2020 |
| 2019 Q4 | 2/13/2020 | 9,807 | 0.1% | 44,791 | 12/31/2019 |